Share

November 25, 2003; 61 (10) Special Article

The use of mitoxantrone (Novantrone) for the treatment of multiple sclerosis [RETIRED]

Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

D.S. Goodin, B.G. Arnason, P.K. Coyle, E.M. Frohman, D.W. Paty
First published November 24, 2003, DOI: https://doi.org/10.1212/01.WNL.0000095425.84407.39
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
18323

Share

Article Information

vol. 61 no. 10 1332-1338
DOI: 
https://doi.org/10.1212/01.WNL.0000095425.84407.39
PubMed: 
14638950
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received December 7, 2001
  • Accepted in final form September 3, 2003
  • First Published November 24, 2003.
Copyright & Usage: 
© 2003

Author Disclosures

    1. D.S. Goodin, MD,
    2. B.G. Arnason, MD,
    3. P.K. Coyle, MD, FAAN,
    4. E.M. Frohman, MD and
    5. D.W. Paty, MD, FAAN
  1. D.S. Goodin, MD,
  2. B.G. Arnason, MD,
  3. P.K. Coyle, MD, FAAN,
  4. E.M. Frohman, MD and
  5. D.W. Paty, MD, FAAN
  1. From the Therapeutics and Technology Assessment Subcommittee, American Academy of Neurology, St. Paul, MN., The University of California, San Francisco is participating in a clinical trial of mitoxantrone in the treatment of primary progressive MS (PI: S. Zamvil). D.S.G. is a participating investigator (without salary) in that trial, which received $161,900 in appropriations from Immunex.
  1. Address correspondence and reprint requests to TTA, American Academy of Neurology, 1080 Montreal Avenue, St. Paul, MN 55116; e-mail: nking{at}aan.com
View Full Text

Article usage

Article usage: November 2003 to February 2023

AbstractFullPdfSource
Nov 2003364657297Highwire
Dec 20034952157748Highwire
Jan 2004161555536Highwire
Feb 2004861049417Highwire
Mar 2004104333449Highwire
Apr 200478233303Highwire
May 2004118300258Highwire
Jun 200489203289Highwire
Jul 200489143254Highwire
Aug 2004130166241Highwire
Sep 200478115232Highwire
Oct 200483116267Highwire
Nov 200470177237Highwire
Dec 200449158214Highwire
Jan 200548325252Highwire
Feb 200583583202Highwire
Mar 200547246203Highwire
Apr 20051738170Highwire
May 20052252145Highwire
Jun 20054743130Highwire
Jul 20052782147Highwire
Aug 20053275198Highwire
Sep 20052160167Highwire
Oct 20053955208Highwire
Nov 20052279171Highwire
Dec 20051751121Highwire
Jan 2006964149Highwire
Feb 20061077138Highwire
Mar 20061759175Highwire
Apr 20061338207Highwire
May 20062944197Highwire
Jun 20062638152Highwire
Jul 20063648143Highwire
Aug 20062335165Highwire
Sep 20062518147Highwire
Oct 20063441187Highwire
Nov 20062222186Highwire
Dec 20061815142Highwire
Jan 20071029178Highwire
Feb 20071830177Highwire
Mar 20072533168Highwire
Apr 20072944190Highwire
May 20071231125Highwire
Jun 20071437119Highwire
Jul 2007124396Highwire
Aug 20071835109Highwire
Sep 20071624107Highwire
Oct 20071724112Highwire
Nov 2007123495Highwire
Dec 2007154687Highwire
Jan 2008212579Highwire
Feb 2008103786Highwire
Mar 20081740103Highwire
Apr 2008224279Highwire
May 2008214571Highwire
Jun 2008104059Highwire
Jul 2008284163Highwire
Aug 2008214260Highwire
Sep 2008373169Highwire
Oct 2008292886Highwire
Nov 20081446116Highwire
Dec 2008161755Highwire
Jan 20092519101Highwire
Feb 2009192190Highwire
Mar 2009282994Highwire
Apr 2009162285Highwire
May 2009202577Highwire
Jun 2009153185Highwire
Jul 2009173378Highwire
Aug 2009151977Highwire
Sep 2009231777Highwire
Oct 2009342497Highwire
Nov 2009271982Highwire
Dec 2009192087Highwire
Jan 2010101975Highwire
Feb 2010162582Highwire
Mar 2010272395Highwire
Apr 20101724106Highwire
May 201091984Highwire
Jun 2010191260Highwire
Jul 2010142566Highwire
Aug 20105960Highwire
Sep 2010101371Highwire
Oct 2010102156Highwire
Nov 201010526Highwire
Dec 2010181255Highwire
Jan 2011101874Highwire
Feb 2011322169Highwire
Mar 2011261780Highwire
Apr 2011191466Highwire
May 2011181367Highwire
Jun 2011141056Highwire
Jul 2011241468Highwire
Aug 2011101467Highwire
Sep 201124973Highwire
Oct 201115560Highwire
Nov 201122756Highwire
Dec 2011181035Highwire
Jan 2012221064Highwire
Feb 201218961Highwire
Mar 2012221773Highwire
Apr 201218961Highwire
May 2012281271Highwire
Jun 2012151738Highwire
Jul 2012151042Highwire
Aug 2012111039Highwire
Sep 2012101346Highwire
Oct 2012201039Highwire
Nov 2012231051Highwire
Dec 201291332Highwire
Jan 2013271467Highwire
Feb 201317938Highwire
Mar 201319743Highwire
Apr 2013341560Highwire
May 201325959Highwire
Jun 201324993Highwire
Jul 2013196150Highwire
Aug 2013107179Highwire
Sep 20131710133Highwire
Oct 2013168171Highwire
Nov 2013269153Highwire
Dec 2013165054Highwire
Jan 2014158047Highwire
Feb 2014177740Highwire
Mar 201499752Highwire
Apr 2014107546Highwire
May 2014107256Highwire
Jun 2014107744Highwire
Jul 20143410439Highwire
Aug 2014126624Highwire
Sep 2014168337Highwire
Oct 2014357613Highwire
Nov 2014168417Highwire
Dec 201419888Highwire
Jan 20151310513Highwire
Feb 2015197617Highwire
Mar 201598113Highwire
Apr 2015108018Highwire
May 20151611321Highwire
Jun 20152110426Highwire
Jul 20157929Highwire
Aug 2015129336Highwire
Sep 201549235Highwire
Oct 2015209216Highwire
Nov 2015546517Highwire
Dec 20151510234Highwire
Jan 2016189437Highwire
Feb 2016133663Highwire
Mar 2016134059Highwire
Apr 201652368Highwire
May 2016134063Highwire
Jun 201692752Highwire
Jul 201654340Highwire
Aug 2016133937Highwire
Sep 201633137Highwire
Oct 2016132326Highwire
Nov 2016114213Highwire
Dec 2016102610Highwire
Jan 2017113711Highwire
Feb 201752810Highwire
Mar 20179329Highwire
Apr 201732510Highwire
May 20177367Highwire
Jun 201733019Highwire
Jul 201752027Highwire
Aug 20173147Highwire
Sep 2017101316Highwire
Oct 201773437Highwire
Nov 201753216Highwire
Dec 201754027Highwire
Jan 2018125637Highwire
Feb 201844718Highwire
Mar 201833626Highwire
Apr 201833632Highwire
May 201845917Highwire
Jun 201811420Highwire
Jul 201832315Highwire
Aug 201831917Highwire
Sep 201805112Highwire
Oct 201854810Highwire
Nov 201868215Highwire
Dec 20183798Highwire
Jan 201927215Highwire
Feb 201945913Highwire
Mar 201922812Highwire
Apr 201901616Highwire
May 201952119Highwire
Jun 201921312Highwire
Jul 201922613Highwire
Aug 201912018Highwire
Sep 201932321Highwire
Oct 201932022Highwire
Nov 201932415Highwire
Dec 201942312Highwire
Jan 20201613Highwire
Feb 2020084813Highwire
Mar 20201615Highwire
Apr 202011612Highwire
May 202041016Highwire
Jun 202031412Highwire
Jul 20203530Highwire
Aug 202001420Highwire
Sep 20202348Highwire
Oct 20203285Highwire
Nov 2020421323Highwire
Dec 202052422Highwire
Jan 20211729Highwire
Feb 20211112937Highwire
Mar 202192924Highwire
Apr 202156631Highwire
May 202192617Highwire
Jun 202172948Highwire
Jul 202142447Highwire
Aug 202132123Highwire
Sep 202142628Highwire
Oct 202132036Highwire
Nov 202112436Highwire
Dec 202142019Highwire
Jan 202251619Highwire
Feb 202231523Highwire
Mar 20223920Highwire
Apr 20226185Highwire
May 202221625Highwire
Jun 202201116Highwire
Jul 202232010Highwire
Aug 2022283Highwire
Sep 202211114Highwire
Oct 202243110Highwire
Nov 20223217Highwire
Dec 2022397Highwire
Jan 20233278Highwire
Feb 202362811Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me

Recommended articles